INTEGRATION OF DNA DAMAGE RESPONSES WITH IMMUNE DEVELOPMENT AND FUNCTION
DNA 损伤反应与免疫发育和功能的整合
基本信息
- 批准号:8686595
- 负责人:
- 金额:$ 12.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-10 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:Antigen ReceptorsApoptosisApoptoticAttenuatedAwardB Cell ProliferationB-LymphocytesBiological Response ModifiersCell CycleCell DeathCell Death Signaling ProcessCell ProliferationCell SurvivalCellsCessation of lifeCharacteristicsChromosomal translocationClinicalCuesCytokine ReceptorsDNADNA DamageDNA Sequence RearrangementDevelopmentDevelopment PlansDiseaseDown-RegulationEnsureEnvironmentEquilibriumEventExtramural ActivitiesFoundationsFundingGene ExpressionGene RearrangementGenerationsGenesGenetic RecombinationGenetic TranscriptionGenomicsGerminationGoalsImmuneImmune responseImmunologic ReceptorsImmunologyIndividualInterleukin-7InvestigationKineticsLaboratory ResearchLeadLymphocyteMalignant NeoplasmsMalignant lymphoid neoplasmMentorsModelingPathogenesisPathway interactionsPhenotypePhysiologicalProcessPropertyProtein-Serine-Threonine KinasesRAG1 geneReceptor GeneReceptor SignalingRegulationResearchSecondary toSignal PathwaySignal TransductionSourceSurfaceT-Cell ReceptorTNFRSF5 geneTechniquesTestingTimeTransactivationWorkattenuationcareercareer developmentcytokineendonucleaseinsightirradiationleukemia/lymphomaleukemogenesismetaplastic cell transformationnovelnucleasepreventprogramsreceptorrepairedresearch studyresponseskillstherapy developmenttooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): Lymphocyte development is precisely controlled to enable generation of a diverse antigen receptor repertoire while, simultaneously, preventing deleterious events, such as translocations, which promote cellular transformation and lymphoid malignancies. These two dichotomous but interdependent processes are managed through the cooperation of diverse cellular signals, which control cell proliferation, survival, and antigen receptor assembly. We describe a novel signaling pathway in pre-B cells that is initiated by the physiologic DNA breaks generated during antigen receptor recombination. Surprisingly, our work demonstrates that DNA break-dependent signals paradoxically activate survival pathways that are important to ensure adequate time for antigen receptor gene rearrangement. However, if DNA breaks cannot be repaired, the same DNA damage responses trigger cell death to prevent translocations and protect genomic integrity. This temporal balance of survival and apoptosis is unique to physiologic DNA breaks as genotoxic insults, such as gamma irradiation, induce immediate cell death without an initial survival period. The goal of this project is to elucidate the mechanisms that coordinate survival and cell death signaling in response to DNA breaks in lymphocytes. Utilizing an experimental approach that permits isolation of DNA break signals and surface receptor signals, we propose to: 1) define the properties of physiologic DNA breaks that control survival kinetics, 2) identify the signals that regulate delayed apoptotic signaling in response to DNA breaks, and 3) define the functional integration of signals from DNA breaks and immune regulators (i.e., CD40) in the regulation of lymphocyte survival. Ultimately, this work will elucidate new signaling networks that balance survival and cell death in
developing lymphocytes to ensure normal maturation and inhibit leukemogenesis. These investigations will establish the foundation for an independent scientific career focused on applying basic immunology research to the pathogenesis of clinical diseases, particularly immune deficiencies and lymphoid malignancies. The mentored period of this award will provide protect time to develop new techniques for studying DNA damage responses in lymphocytes and to acquire new skills necessary for managing a research laboratory. These tools will be essential for completion of the outlined experiments and for the germination of an independent research program. A collaborative and robust immunology research environment will help guide future research directions. This application presents a research program and a career development plan that will provide the framework and skills necessary for establishing independence and competing for extramural funding.
描述(由申请人提供):精确控制淋巴细胞的发育以产生多样化的抗原受体库,而同时可以预防有害事件,例如易位,从而促进细胞转化和淋巴瘤恶性肿瘤。这两个二分法但相互依存的过程是通过多种细胞信号的合作来管理的,该信号控制细胞增殖,存活和抗原受体组装。我们描述了Pre-B细胞中的一种新型信号通路,该信号通路是由在抗原受体重组过程中产生的生理DNA断裂引发的。令人惊讶的是,我们的工作表明,DNA断裂信号矛盾地激活生存途径,这对于确保足够的抗原受体基因重排的时间很重要。但是,如果无法修复DNA断裂,则相同的DNA损伤反应会触发细胞死亡,以防止易位并保护基因组完整性。生存和凋亡的这种时间平衡是生理DNA的特有的,例如遗传毒性损伤,例如伽马射线,诱导没有初始生存期的立即细胞死亡。该项目的目的是阐明响应淋巴细胞中DNA断裂的生存和细胞死亡信号的机制。利用允许隔离DNA断裂信号和表面受体信号的实验方法,我们建议:1)定义控制生存动力学的生理DNA的特性,2)确定调节对DNA响应的延迟凋亡信号的信号,并定义DNA响应的响应,并定义DNA的功能范围(3))(3)定义了DNA的功能(3))(3))(3))(3)淋巴细胞存活。最终,这项工作将阐明平衡生存和细胞死亡的新信号网络
发展淋巴细胞,以确保正常的成熟并抑制白血病。这些调查将为一个独立的科学生涯奠定基础,该职业专注于将基本免疫学研究应用于临床疾病的发病机理,尤其是免疫缺陷和淋巴恶性肿瘤。该奖项的指导期限将为开发新技术提供研究,以研究淋巴细胞中DNA损伤反应的新技术,并获得管理研究实验室所需的新技能。这些工具对于完成概述的实验以及独立研究计划的发芽至关重要。协作和强大的免疫学研究环境将有助于指导未来的研究方向。该应用程序提出了一项研究计划和职业发展计划,该计划将提供建立独立性和争夺壁外资金所需的框架和技能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey J Bednarski其他文献
Jeffrey J Bednarski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey J Bednarski', 18)}}的其他基金
MYSM1-dependent DNA damage responses in early B cell development
早期 B 细胞发育中 MYSM1 依赖性 DNA 损伤反应
- 批准号:
10527156 - 财政年份:2022
- 资助金额:
$ 12.68万 - 项目类别:
MYSM1-dependent DNA damage responses in early B cell development
早期 B 细胞发育中 MYSM1 依赖性 DNA 损伤反应
- 批准号:
10630928 - 财政年份:2022
- 资助金额:
$ 12.68万 - 项目类别:
RAG-mediated DNA Damage Responses in Immune Development and Function
RAG 介导的免疫发育和功能中的 DNA 损伤反应
- 批准号:
10566822 - 财政年份:2022
- 资助金额:
$ 12.68万 - 项目类别:
RAG-mediated DNA Damage Responses in Immune Development and Function
RAG 介导的免疫发育和功能中的 DNA 损伤反应
- 批准号:
10707193 - 财政年份:2022
- 资助金额:
$ 12.68万 - 项目类别:
Role of DNA Damage Responses in Immune Development and Function
DNA 损伤反应在免疫发育和功能中的作用
- 批准号:
10197574 - 财政年份:2020
- 资助金额:
$ 12.68万 - 项目类别:
INTEGRATION OF DNA DAMAGE RESPONSES WITH IMMUNE DEVELOPMENT AND FUNCTION
DNA 损伤反应与免疫发育和功能的整合
- 批准号:
8527706 - 财政年份:2012
- 资助金额:
$ 12.68万 - 项目类别:
INTEGRATION OF DNA DAMAGE RESPONSES WITH IMMUNE DEVELOPMENT AND FUNCTION
DNA 损伤反应与免疫发育和功能的整合
- 批准号:
8423431 - 财政年份:2012
- 资助金额:
$ 12.68万 - 项目类别:
INTEGRATION OF DNA DAMAGE RESPONSES WITH IMMUNE DEVELOPMENT AND FUNCTION
DNA 损伤反应与免疫发育和功能的整合
- 批准号:
9096703 - 财政年份:2012
- 资助金额:
$ 12.68万 - 项目类别:
相似国自然基金
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
- 批准号:82303959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
- 批准号:82300769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Regulation of Peripheral Neuropathic Pain by B Cells
B 细胞对周围神经病理性疼痛的调节
- 批准号:
10417954 - 财政年份:2022
- 资助金额:
$ 12.68万 - 项目类别:
The Role of Pacs1-Wdr37 inLymphocyte Quiescence and Survival
Pacs1-Wdr37 在淋巴细胞静止和存活中的作用
- 批准号:
10416951 - 财政年份:2022
- 资助金额:
$ 12.68万 - 项目类别:
Regulation of Peripheral Neuropathic Pain by B Cells
B 细胞对周围神经病理性疼痛的调节
- 批准号:
10588250 - 财政年份:2022
- 资助金额:
$ 12.68万 - 项目类别:
The Role of Pacs1-Wdr37 inLymphocyte Quiescence and Survival
Pacs1-Wdr37 在淋巴细胞静止和存活中的作用
- 批准号:
10569565 - 财政年份:2022
- 资助金额:
$ 12.68万 - 项目类别: